ATP18 Antibody

What is ATP18 and why is it important in scientific research?

ATP18 is a subunit of the ATP synthase complex, primarily studied in model organisms like Schizosaccharomyces pombe (fission yeast). It plays a critical role in mitochondrial energy production as part of the machinery that generates ATP through oxidative phosphorylation.

ATP18 research is significant because it provides insights into:

• Fundamental mechanisms of cellular energy production

• Mitochondrial function and dysfunction

• Evolutionary conservation of ATP synthase components

• Potential therapeutic targets for mitochondrial disorders

The ATP18 protein (UniProt No. O13931) from S. pombe serves as an important model for understanding ATP synthase assembly and function in eukaryotic cells . While structurally distinct from human ATP synthase components, the core functional mechanisms remain conserved, making it valuable for translational research.

What experimental applications are ATP18 antibodies suitable for?

ATP18 antibodies have been validated for several key applications in molecular and cellular biology research:

When selecting an ATP18 antibody, researchers should consider whether it has been validated for their specific application and model organism. The commercially available ATP18 antibody described in the search results is specifically raised against and reactive with S. pombe ATP18 protein .

How should researchers validate ATP18 antibody specificity?

Proper validation of ATP18 antibody specificity is critical for experimental reliability. A comprehensive validation approach includes:

• Western blot analysis:

  • Confirm single band at expected molecular weight

  • Compare with genetic knockouts/knockdowns when available

  • Perform peptide competition assays to verify epitope specificity

• Recombinant protein controls:

  • Test reactivity against purified recombinant ATP18

  • Compare with related ATP synthase subunits to assess cross-reactivity

• Genetic approaches:

  • Test in ATP18-null mutants (should show no signal)

  • Test in ATP18-overexpressing systems (should show increased signal)

• Orthogonal methods:

  • Confirm findings with alternative detection methods

  • Verify localization patterns match known distribution

Similar validation approaches have been successfully used for other ATP synthase antibodies, as demonstrated in studies of ATP synthase on endothelial cells where antibody specificity was verified through competition assays with recombinant protein .

How can researchers optimize ATP18 antibody use in immunofluorescence microscopy?

Optimizing immunofluorescence protocols for ATP18 requires careful attention to several parameters:

• Fixation and permeabilization:

  • Paraformaldehyde (4%) for 15-20 minutes preserves mitochondrial structure

  • Gentle permeabilization with 0.1% Triton X-100 or 0.1% saponin

  • Cold methanol fixation (-20°C, 10 minutes) provides an alternative approach

• Blocking and antibody incubation:

  • Use 5% BSA or 10% normal serum from secondary antibody host species

  • Incubate primary antibody overnight at 4°C for optimal signal-to-noise ratio

  • Dilution range: typically start at 1:100-1:250 and optimize

• Co-localization strategies:

  • Pair ATP18 antibody with established mitochondrial markers

  • Consider dual staining with other ATP synthase subunits

  • Use Z-stack imaging to fully capture mitochondrial networks

• Signal amplification options:

  • Tyramide signal amplification for low abundance detection

  • Quantum dot conjugates for improved photostability

  • Anti-rabbit IgG conjugated to bright fluorophores like Cy3 or Alexa Fluor dyes

For visualization of mitochondrial ATP synthase components, approaches similar to those used in studies of ATP synthase on human endothelial cells have proven effective, where cells were incubated with primary antibody at 4°C followed by fluorophore-conjugated secondary antibody and examination by fluorescence microscopy .

What are the key considerations when using ATP18 antibodies for protein complex analysis?

Analysis of ATP18-containing protein complexes presents unique challenges:

• Sample preparation for intact complexes:

  • Gentle cell lysis using non-ionic detergents (digitonin 0.5-1%)

  • Avoid heating samples when possible

  • Consider chemical crosslinking to stabilize transient interactions

• Immunoprecipitation optimization:

  • Use mild detergents to solubilize membrane complexes

  • Consider native immunoprecipitation conditions

  • Optimize antibody-to-protein ratio

• Blue Native PAGE approach:

  • Preserve native complex structure with mild solubilization

  • Run in parallel with SDS-PAGE for subunit composition analysis

  • Follow with Western blotting for specific detection

• Mass spectrometry integration:

  • On-bead digestion to identify interaction partners

  • Crosslinking mass spectrometry for structural information

  • Label-free quantification to assess complex stoichiometry

Research on ATP synthase complexes has demonstrated the value of combining immunoprecipitation with mass spectrometry for identification of interacting proteins, a strategy that can be adapted specifically for ATP18 studies .

How do buffer conditions affect ATP18 antibody performance in biochemical assays?

Buffer composition significantly impacts ATP18 antibody performance across different applications:

For ATP synthase components, specialized buffers have been developed that maintain complex integrity while allowing antibody access to epitopes. Studies of ATP synthase on human endothelial cells successfully employed PBS pH 7.0 containing 1% BSA for antibody incubation .

What techniques can be used to study ATP18 in the context of ATP synthase dynamics?

Several advanced techniques enable investigation of ATP18's role in ATP synthase dynamics:

• Live-cell imaging approaches:

  • Fluorescent protein tagging of ATP18 (if function is preserved)

  • Antibody fragment labeling for live-cell applications

  • Correlative light-electron microscopy for structural context

• Pulse-chase analysis:

  • Monitor ATP18 incorporation into complexes over time

  • Track turnover rates under different conditions

  • Assess effects of inhibitors or genetic perturbations

• FRAP (Fluorescence Recovery After Photobleaching):

  • Measure mobility and exchange rates of ATP18

  • Compare wild-type vs. mutant dynamics

  • Assess impact of metabolic conditions

• Proximity labeling techniques:

  • BioID or APEX2 fusion to identify proximity partners

  • Temporal mapping of assembly intermediates

  • Identification of transient interactions

• Cryo-electron microscopy:

  • Structural analysis of ATP18 within the ATP synthase complex

  • Comparison of different functional states

  • Integration with antibody labeling for subunit localization

These approaches build on methods used in ATP synthase research, where advanced imaging and biochemical techniques have revealed insights into complex assembly and function .

How can ATP18 antibodies be applied in studying extracellular ATP signaling?

While ATP18 itself is a mitochondrial protein, ATP18 antibodies can contribute to research on extracellular ATP signaling through several approaches:

• Analysis of ATP release mechanisms:

  • Correlation of ATP synthase activity with extracellular ATP levels

  • Investigation of ectopic ATP synthase components on cell surfaces

  • Examination of ATP18 involvement in ATP release pathways

• Cancer research applications:

  • Study of elevated extracellular ATP in tumor microenvironments

  • Investigation of ATP-dependent antibody targeting strategies

  • Correlation of ATP18 expression with extracellular ATP levels

• Cell death and ATP release:

  • Monitoring ATP release during immunogenic cell death

  • Correlation with ATP18 levels and ATP synthase function

  • Analysis of cancer cell response to therapy

Research has demonstrated that extracellular ATP is elevated in tumor microenvironments and can be exploited for targeting antibodies specifically to tumors . Additionally, cells infected with oncolytic viruses expressing bispecific T cell engagers showed increased ATP release, indicating immunogenic cell death .

What controls should be included when working with ATP18 antibodies?

A comprehensive control strategy ensures reliable results with ATP18 antibodies:

• Positive controls:

  • Recombinant ATP18 protein

  • Cell lines/tissues known to express ATP18

  • Overexpression systems with tagged ATP18

• Negative controls:

  • ATP18 knockout/knockdown samples

  • Cell lines lacking target expression

  • Secondary antibody-only controls

• Specificity controls:

  • Peptide competition/blocking

  • Pre-immune serum comparison

  • Isotype control antibodies

• Procedural controls:

  • Loading controls for Western blots (e.g., housekeeping proteins)

  • Subcellular fractionation markers

  • Cross-reactivity assessment in multiple species if relevant

Studies of ATP synthase have successfully employed competition controls, where antibody was preincubated with recombinant protein to demonstrate binding specificity. For example, A549 cells analyzed with anti-α-subunit ATP synthase antibody preincubated with recombinant protein showed decreased binding, confirming specificity .

How can researchers optimize the detection of low-abundance ATP18 protein?

Detecting low-abundance ATP18 requires specialized approaches:

• Sample enrichment strategies:

  • Mitochondrial isolation/enrichment

  • Immunoprecipitation followed by Western blotting

  • Subcellular fractionation to concentrate target

• Signal amplification methods:

  • Tyramide signal amplification for immunohistochemistry/immunofluorescence

  • Enhanced chemiluminescence substrates for Western blotting

  • Quantum dot conjugates for improved detection sensitivity

• Instrument optimization:

  • Increased exposure time (with appropriate controls)

  • Sensitive detection systems (e.g., cooled CCD cameras)

  • Confocal microscopy with photomultiplier tube optimization

• Protocol refinements:

  • Extended primary antibody incubation (overnight at 4°C)

  • Optimized blocking to improve signal-to-noise ratio

  • Multiple antibody application with gentle washing

For flow cytometry applications, similar approaches to those used for detecting cell surface ATP synthase could be adapted, where specific, saturable binding of antibody was demonstrated through careful titration experiments .

What are the common pitfalls when using ATP18 antibodies and how can they be avoided?

Researchers should be aware of several common challenges:

To address these issues, researchers can implement strategies similar to those used in ATP synthase studies where careful optimization of antibody concentration, incubation conditions, and comprehensive controls ensured reliable detection .

How can ATP18 antibodies be used to investigate mitochondrial diseases?

ATP18 antibodies offer valuable tools for mitochondrial disease research:

• Diagnostic applications:

  • Assessment of ATP18 levels in patient samples

  • Analysis of ATP synthase assembly defects

  • Correlation with clinical phenotypes

• Mechanistic studies:

  • Investigation of ATP18 incorporation into ATP synthase

  • Analysis of compensatory mechanisms

  • Identification of disease-associated protein interactions

• Therapeutic monitoring:

  • Evaluation of treatment effects on ATP18 expression

  • Assessment of ATP synthase assembly restoration

  • Correlation with mitochondrial function improvement

• Model system validation:

  • Comparison of patient samples with cellular/animal models

  • Verification of disease mechanism in experimental systems

  • Testing of therapeutic approaches

Research using antibodies against ATP synthase components has provided insights into disorders characterized by ATP synthase dysfunction, demonstrating the value of immunological approaches in understanding mitochondrial diseases .

What approaches enable ATP18 antibody use in high-throughput screening?

Adapting ATP18 antibodies for high-throughput applications:

• Assay miniaturization:

  • 384/1536-well format ELISA optimization

  • Automated Western blotting systems

  • High-content imaging platforms

• Detection technologies:

  • Time-resolved fluorescence

  • AlphaLISA/AlphaScreen assays

  • Automated immunofluorescence platforms

• Readout optimization:

  • Direct fluorophore conjugation to primary antibody

  • Elimination of wash steps (homogeneous assays)

  • Stable cell lines with reporter systems

• Data analysis approaches:

  • Automated image analysis algorithms

  • Machine learning for phenotypic classification

  • Integration with other high-throughput data types

Similar high-throughput approaches have been applied to ATP synthase research in the context of drug discovery and biochemical screening, providing a foundation for ATP18-specific applications .

How do post-translational modifications affect ATP18 antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody-epitope interactions:

• Common PTMs affecting recognition:

  • Phosphorylation: May create steric hindrance

  • Acetylation: Can alter epitope charge

  • Oxidation: May change protein folding

  • Proteolytic processing: Can remove epitopes entirely

• Consequences for experimental outcomes:

  • False negatives if PTMs block epitope

  • Signal intensity variation based on modification state

  • Different results across experimental conditions

• Strategic approaches:

  • Use multiple antibodies targeting different epitopes

  • Develop modification-specific antibodies when relevant

  • Include treatments to remove modifications as controls

  • Combine with mass spectrometry to identify PTMs

This approach builds on methodology used in ATP synthase research, where careful characterization of epitope accessibility under different conditions ensured reliable detection .

What are the considerations for using ATP18 antibodies in comparative model organism research?

When applying ATP18 antibodies across different model systems:

• Epitope conservation analysis:

  • Sequence alignment across species

  • Structural prediction of epitope accessibility

  • Empirical testing in each model organism

• Cross-reactivity validation:

  • Western blotting in multiple species

  • Immunoprecipitation followed by mass spectrometry

  • Genetic controls (knockouts/knockdowns) when available

• Application-specific optimization:

  • Species-specific fixation protocols

  • Buffer adjustments for different tissues/cells

  • Blocking reagent optimization

• Interpretation considerations:

  • Evolutionary differences in ATP synthase structure

  • Functional conservation despite sequence divergence

  • Species-specific PTMs and interacting partners

The ATP18 antibody described in the search results is specifically raised against S. pombe ATP18 , so researchers working with other organisms would need to carefully validate cross-reactivity before proceeding with experiments.

How can ATP18 antibodies contribute to cancer metabolism research?

ATP18 antibodies offer several approaches for investigating cancer metabolism:

• ATP synthase expression and localization:

  • Quantification of ATP18 in tumor vs. normal tissues

  • Analysis of subcellular distribution in cancer cells

  • Correlation with metabolic phenotypes

• Integration with metabolic profiling:

  • Correlation of ATP18 levels with ATP production

  • Analysis of glycolytic vs. oxidative phosphorylation reliance

  • Investigation of metabolic flexibility mechanisms

• Therapeutic applications:

  • Targeting ATP synthase in cancer

  • Monitoring metabolic adaptation to therapy

  • Exploiting unique metabolic features of tumors

Research has demonstrated that elevated extracellular ATP in tumor microenvironments can be exploited for targeting therapeutic antibodies specifically to tumors, overcoming on-target off-tumor toxicity . Additionally, ATP release during oncolytic virus treatment of cancer cells suggests activation of immunogenic cell death pathways .